EVALUATION OF SALIVARY BİOMARKER LEVELS IN SMOKING AND NON-SMOKER INDIVIDUALS WITH DIFFERENT PERIODONTAL DISEASES
EVALUATION OF SALIVARY HMGB1, sTREM-1 AND TNF-α LEVELS IN SMOKING AND NON-SMOKER INDIVIDUALS WITH DIFFERENT PERIODONTAL DISEASES
1 other identifier
interventional
80
1 country
1
Brief Summary
This study aimed to compare various cytokine levels in saliva samples in order to understand the pathogenesis of chronic inflammatory diseases. In particular, HMGB1, sTREM-1 and TNF-α levels were examined between smokers and non-smokers with periodontitis and non-smokers with gingivitis and periodontally healthy individuals. 80 systemically healthy individuals were included in the study. These individuals were divided into four groups: 20 non-smoker periodontally healthy, 20 non-smoker with gingivitis, 20 non- smokers with periodontitis and 20 smokers with periodontitis. Periodontal clinical parameters of each individual were measured and saliva samples were taken. HMGB1, sTREM-1 and TNF-α levels in the saliva samples were determined by enzyme-linked immunoassay (ELISA) method. Statistical analyses were performed on the data to examine the differences in cytokine levels between the groups and the relationships of these cytokines with clinical parameters. The findings obtained may contribute to the research of potential biomarkers that can be used in the diagnosis of periodontal diseases and new ways of treatment processes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 7, 2025
CompletedFirst Posted
Study publicly available on registry
May 14, 2025
CompletedMay 14, 2025
May 1, 2025
7 months
May 7, 2025
May 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Salivary TNF-α levels
the total amount of TNF-α in saliva
24 hours after taking the clinical measurements at the first visit
Salivary sTREM-1 level
the total amount of sTREM-1 in saliva
24 hours after taking the clinical measurements at the first visit
Salivary HMGB-1 levels
the total amount of HMGB-1 in saliva
24 hours after taking the clinical measurements at the first visit
Secondary Outcomes (5)
Probing Depth
during the initial visit
clinical attachment level
during the initial visit
Plaque Index
during the initial visit
gingival index
during the initial visit
bleeding on probing
during the initial visit
Study Arms (4)
Healthy periodontium
EXPERIMENTALIndividuals who, in the evaluation made in 6 areas of each tooth, had bleeding on probing in less than 10% of the areas, had a probing depth of less than 4 mm and had no attachment loss.
gingivitis
EXPERIMENTALIndividuals who have bleeding on probing in more than 10% of the areas, a probing depth of less than 4 mm and no attachment loss, based on an evaluation of 6 areas of each tooth.
non-smoker periodontitis
EXPERIMENTALIndividuals who have bleeding on probing in 30% or more areas according to the evaluation made in 6 areas of each tooth, who have a probing pocket depth of 5 mm or more in at least 2 non-adjacent teeth in each quadrant of the jaw and who have attachment loss of 4 mm or more, and who have coronal 1/3 or more (horizontal and/or vertical) bone loss on radiographs.
smoker periodontitis
EXPERIMENTALIndividuals who smoke at least 10 cigarettes a day, who have bleeding on probing in 30% or more areas according to the evaluation made in 6 areas of each tooth, who have a probing pocket depth of 5 mm or more in at least 2 non-adjacent teeth in each quadrant of the jaw and who have attachment loss of 4 mm or more, and who have coronal 1/3 or more (horizontal and/or vertical) bone loss on radiographs.
Interventions
The patient was asked to sit upright and tilt his/her head forward to collect saliva samples. İn this way, unstimulated saliva was allowed to accumulate in the floor of the mouth. The accumulated saliva was collected in a sterile container. It was then transferred to a propylene tube. The tubes were centrifuged and the clear part at the top of the tube was taken with a sterile syringe and transferred to a different propylene tube with 0.5 ml in each tube. Tubes were stored at -80ºC until the day of analysis.
Eligibility Criteria
You may qualify if:
- Systemically healthy (Determination of volunteers will be based on patient statements in the anamnesis. No additional examination will be performed.)
- At least 16 permanent teeth in the mouth
- For non-smoking groups: never smoked
- For the smoking group: smoking at least 10 cigarettes per day
- No continuously used medications
- No use of antibiotics, anti-inflammatory drugs, and systemic corticosteroids in the last 6 months
- Not pregnant or breastfeeding
- No periodontal treatment in the last 6 months
- For the Periodontitis group: based on the evaluation of 6 sites per tooth, ≥30% bleeding on probing, probing depth ≥5 mm and clinical attachment loss ≥4 mm in at least 2 non-adjacent teeth in a quadrant, and radiographic bone loss of coronal 1/3 or more (horizontal and/or vertical)
- For the Gingivitis group: based on the evaluation of 6 sites per tooth, ≥10% bleeding on probing, probing depth \<4 mm, and no clinical attachment loss
- For the Healthy group: based on the evaluation of 6 sites per tooth, \<10% bleeding on probing, probing depth \<4 mm, and no clinical attachment loss.
You may not qualify if:
- Any oral or systemic disease
- Regularly using a systemic medication
- During pregnancy or lactation
- Received periodontal treatment within the last 6 months.
- Those who received antibiotic, anti-inflammatory or systemic corticosteroid medication in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir Katip Çelebi University Department of Periodontology
Izmir, Çiğli, 35640, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant of Periodontology
Study Record Dates
First Submitted
May 7, 2025
First Posted
May 14, 2025
Study Start
April 1, 2024
Primary Completion
November 1, 2024
Study Completion
February 1, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share